Experienced in Localized Scleroderma

Dr. Alexei A. Grom

Pediatric Rheumatology | Rheumatology
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
Accepting New Patients
Experienced in Localized Scleroderma
Children's Hospital Medical Center
3333 Burnet Ave, 
Cincinnati, OH 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Alexei Grom is a Pediatric Rheumatologist and a Rheumatologist in Cincinnati, Ohio. Dr. Grom is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Juvenile Idiopathic Arthritis (JIA), Arthritis, Mevalonate Kinase Deficiency, Pulmonary Alveolar Proteinosis, and Bone Marrow Aspiration. Dr. Grom is currently accepting new patients.

His clinical research consists of co-authoring 95 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Pediatric Rheumatology
Rheumatology
Licenses
Pediatric Rheumatology in OH
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Health Services
  • EPO
  • MANAGED MEDICAID PLAN
  • OTHER COMMERCIAL
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Medical Health
  • HMO
  • PPO
Oscar
  • EPO
  • HMO
  • PPO
TeamCare
  • OTHER COMMERCIAL
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 10 Less Insurance Carriers -

Locations

CHILDREN'S HOSPITAL MEDICAL CENTER
3333 Burnet Ave, Cincinnati, OH 45229

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Three-period Multicenter Study, With a Randomized-withdrawal, Double-blind, Placebo-controlled Design to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
A Three-period Multicenter Study, With a Randomized-withdrawal, Double-blind, Placebo-controlled Design to Evaluate the Clinical Efficacy, Safety and Tolerability of MAS825 in Patients With Monogenic IL-18 Driven Autoinflammatory Diseases, Including NLRC4-GOF, XIAP Deficiency, or CDC42 Mutations
Enrollment Status: Active_not_recruiting
Publish Date: August 27, 2025
Intervention Type: Biological
Study Drug: MAS825
Study Phase: Phase 2
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
A Multicenter Study for the Long-term Follow-up of HLH Patients Who Received Treatment With NI-0501, an Anti-interferon Gamma Monoclonal Antibody
Enrollment Status: Completed
Publish Date: June 28, 2022
Intervention Type: Drug
Study Phase: Phase 2/Phase 3
A Pilot, Open-label, Single Arm, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Administrations of Emapalumab, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)
A Pilot, Open-label, Single Arm, Multicenter Study to Evaluate Safety, Tolerability, Pharmacokinetics and Efficacy of Intravenous Administrations of Emapalumab, an Anti-interferon Gamma (Anti-IFNγ) Monoclonal Antibody, in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)
Enrollment Status: Completed
Publish Date: May 17, 2022
Intervention Type: Drug
Study Drug: Emapalumab Anti-IFN-Gamma Antibody
Study Phase: Phase 2
View 2 Less Clinical Trials

95 Total Publications

Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis.
Utility of patient-reported outcomes for pulmonary symptoms and sleep disturbance and impairment in children with systemic juvenile idiopathic arthritis.
Journal: Pediatric rheumatology online journal
Published: March 10, 2025
Similar Doctors
Advanced in Localized Scleroderma
Dr. Tracy V. Ting
Pediatric Rheumatology | Rheumatology
Advanced in Localized Scleroderma
Dr. Tracy V. Ting
Pediatric Rheumatology | Rheumatology

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Tracy Ting is a Pediatric Rheumatologist and a Rheumatologist in Cincinnati, Ohio. Dr. Ting is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Juvenile Dermatomyositis, Juvenile Idiopathic Arthritis (JIA), Ehlers-Danlos Syndrome (EDS), and Localized Scleroderma. Dr. Ting is currently accepting new patients.

Experienced in Localized Scleroderma
Dr. Jackeline J. Rodriguez-Smith
Pediatric Rheumatology | Pediatrics
Experienced in Localized Scleroderma
Dr. Jackeline J. Rodriguez-Smith
Pediatric Rheumatology | Pediatrics

Children's Hospital Medical Center

3333 Burnet Ave, 
Cincinnati, OH 
 (0.1 miles away)
513-636-4200
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Jackeline Rodriguez-Smith is a Pediatric Rheumatologist and a Pediatrics provider in Cincinnati, Ohio. Dr. Rodriguez-Smith is rated as an Experienced provider by MediFind in the treatment of Localized Scleroderma. Her top areas of expertise are Juvenile Idiopathic Arthritis (JIA), Localized Scleroderma, Juvenile Dermatomyositis, and PFAPA. Dr. Rodriguez-Smith is currently accepting new patients.

Experienced in Localized Scleroderma
Dr. Dustin E. Fleck
Pediatric Rheumatology | Pediatrics | Rheumatology
Experienced in Localized Scleroderma
Dr. Dustin E. Fleck
Pediatric Rheumatology | Pediatrics | Rheumatology
3333 W Tech Rd, 
Miamisburg, OH 
 (34.0 miles away)
937-641-4000
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Dustin Fleck is a Pediatric Rheumatologist and a Pediatrics provider in Miamisburg, Ohio. Dr. Fleck is rated as an Advanced provider by MediFind in the treatment of Localized Scleroderma. His top areas of expertise are Mevalonate Kinase Deficiency, Juvenile Dermatomyositis, Raynaud Phenomenon, and Ehlers-Danlos Syndrome (EDS). Dr. Fleck is currently accepting new patients.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Grom's expertise for a condition
ConditionClose
View All 25 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile